Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Zepbound Tops Wegovy for Weight Loss
Eli Lilly Chief Scientific Officer explains Zepbound's weight loss advantage
Dan Skovronsky, Eli Lilly Chief Scientific Officer, joins 'Fast Money' to talk Zepbound's recent trial results and what it means for Eli Lilly's future growth.
Eli Lilly's Zepbound beats Wegovy in head-to-head weight loss trial
Eli Lilly said patients taking its obesity drug Zepbound lost 47% more weight than those who were given Novo Nordisk's Wegovy in a study.
Zepbound tops Wegovy for weight loss in Eli Lilly study
Shares of Eli Lilly climbed early Wednesday after the drugmaker detailed a study showing that its blockbuster weight-loss drug Zepbound helped patients shed more pounds than Wegovy from rival Novo Nordisk.
Lilly invests $3 billion to expand Wisconsin plant
Eli Lilly to Expand Facility to Meet Demand for Diabetes, Obesity Treatments
Eli
Lilly
said it would invest $3 billion to expand a recently ... The decision comes months after
Lilly
resolved shortages for its weight-loss and diabetes drugs,
Zepbound
and Mounjaro.
Lilly
’s rival, Novo Nordisk, has been expanding its production ...
Eli Lilly invests $3B to expand Wisconsin factory to help meet demand for Mounjaro, Zepbound
Eli Lilly is spending another $3 billion to bulk up manufacturing as the drugmaker seeks to stoke production of some blockbuster drugs and future products
Lilly invests $3 billion to expand Wisconsin plant as obesity drug demand soars
Eli Lilly said on Thursday it will invest $3 billion to expand the manufacturing plant it bought in Pleasant Prairie, Wisconsin earlier this year, as it scrambles to meet soaring demand for its weight-loss and diabetes drugs.
2h
Eli Lilly’s $3 billion expansion in Kenosha County will mean 750 new jobs
Eli Lilly has announced a $3 billion expansion in Kenosha County to its manufacturing facility acquired earlier this year in ...
Yahoo Finance
10h
The Weight Loss Drug Race Heats Up: Eli Lilly's Zepbound Outperforms Wegovy in Weight Loss Trials
Eli
Lilly
(NYSE:LLY) has been making headlines recently with its weight-loss drug
Zepbound
(tirzepatide).
Eli
Lilly
...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Tsunami warnings lifted
French government falls
Fox News commentator dies
Images of suspect released
Set to return after 20 years
Congress halts Ukraine aid
Recuses himself from case
May cut diabetes risk
Nadler to step aside
Airbus layoffs
Winter storm to hit US
Billy Long to lead IRS
Theriault ends recount
MX record fentanyl bust
Independent run for gov.
Rockefeller tree lights up
Recalls over 205,000 SUVs
US telecom firms hacked
$10B AI data center in LA
Social Security chief pick
Composer Laird dies at 85
Leaded gas health risk
DOJ: Bias against Blacks
Taiwan's pres visits Guam
Tops $100K for the first time
Medellin cartel leader freed
Prenatal test spots cancer?
US trade deficit shrinks
Satellites to create eclipses
SpaceX sets record
Weekly jobless claims rise
Raw milk recall expands
Airlines to pay for delays?
Syrian rebels capture Hama
New AI tools for employees
Delays oil output hike
Related topics
Wegovy
Novo Nordisk
Amgen
Glucagon-like peptide-1
Feedback